Loading…
Firefly Neuroscience, Inc. is projected to decline to $1.07 by 2027, a -9% move from its current price of $1.17. AIFF is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.13 | $1.17 | $1.21 | -0.11% |
| Aug 6 | $1.11 | $1.17 | $1.23 | -0.23% |
| Aug 7 | $1.10 | $1.17 | $1.24 | -0.34% |
| Aug 8 | $1.08 | $1.16 | $1.25 | -0.46% |
| Aug 9 | $1.07 | $1.16 | $1.26 | -0.57% |
| Aug 10 | $1.06 | $1.16 | $1.27 | -0.68% |
| Aug 11 | $1.06 | $1.16 | $1.28 | -0.80% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.06 | $1.16 | $1.28 | -0.80% |
| Week 2 | $1.01 | $1.15 | $1.32 | -1.59% |
| Week 3 | $0.9702 | $1.14 | $1.34 | -2.38% |
| Week 4 | $0.9385 | $1.13 | $1.37 | -3.16% |
| Week 5 | $0.9105 | $1.12 | $1.39 | -3.93% |
| Week 6 | $0.8853 | $1.12 | $1.40 | -4.70% |
| Week 7 | $0.8621 | $1.11 | $1.42 | -5.46% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America.
The Evoke System performs electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians.
Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York. It serves clinicians.
Firefly Neuroscience, Inc. (AIFF) currently trades at $1.01 and has a market capitalization of $15.76M. It is ranked 4673 by market size. The price outlook based on the forecast shows mixed near-term results with potential long-term upside, including bullish milestones in the 2032, 2035, 2040, and 2050 timeframes.
The 2050 forecast max price is $5.85 with a ROI of 186.8 and a neutral overall sentiment.
For context, the forecast projects 2026 with min $0.64, avg $1.01, max $1.17 (ROI 0) and 2030 with min $0.84, avg $1.18, max $1.80 (ROI 17.1). The later years show rising targets, with 2040 max $3.01 (ROI 64) and 2050 max $5.85 (ROI 186.8).
A major floor 32.5% below — a decisive break under it would weaken the trend.
The nearest floor, 13.7% below — buyers have tended to step in here.
The nearest ceiling, 17.1% above — a clean break opens room to run.
A major ceiling 158.1% above — clearing it would confirm fresh momentum.
Key AIFF support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AIFF market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.09 | Buy | $1.07 | Buy |
| MA 10 | $1.11 | Buy | $1.10 | Buy |
| MA 20 | $1.15 | Buy | $1.16 | Buy |
| MA 50 | $1.37 | Sell | $1.33 | Sell |
| MA 100 | $1.67 | Sell | $1.47 | Sell |
| MA 200 | $1.51 | Sell | $1.75 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.04 | Neutral |
| Stoch RSI (14) | 62.22 | Neutral |
| CCI (20) | -106.58 | Sell |
| Williams %R (14) | -64.71 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -7.76 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 35.29 | Neutral |
| TRIX (15) | -1.01 | Sell |
| Awesome (5,34) | -0.14 | Sell |
| Ultimate (7,14,28) | 41.04 | Neutral |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 1.04 | Buy |
| ADX (14) | 29.18 | Sell |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is neutral, with RSI14 at 30. The 50-day simple moving average is $1.39 and the 200-day simple moving average is $1.52. Near-term support is at $1.01 and resistance is at $1.44, with a 30-day range from $0.8066 to $1.26. Annualized volatility is 70%.
These indicators suggest the price could hover around the current level, with limited downside near the $1.01 support and potential upside toward the $1.44 resistance in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.64 | $1.17 | $1.36 | 0% | Neutral | |
| $0.8283 | $1.07 | $1.47 | -9% | Neutral | |
| $0.7991 | $1.07 | $1.54 | -9% | Neutral | |
| $0.912 | $1.26 | $1.88 | +8% | Neutral | |
| $0.9626 | $1.37 | $2.11 | +17% | Neutral | |
| $0.9547 | $1.39 | $2.20 | +19% | Neutral | |
| $0.971 | $1.45 | $2.35 | +24% | Bullish | |
| $0.8261 | $1.26 | $2.09 | +8% | Neutral | |
| $0.8036 | $1.26 | $2.12 | +7% | Neutral | |
| $0.9234 | $1.47 | $2.53 | +26% | Bullish | |
| $1.08 | $1.91 | $3.53 | +63% | Bullish | |
| $1.60 | $3.36 | $6.91 | +187% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.64 | $1.17 | $1.42 | +0.00% |
| September 2026 | $0.9272 | $1.11 | $1.36 | -5.48% |
| October 2026 | $0.8757 | $1.05 | $1.32 | -4.69% |
| November 2026 | $0.8843 | $1.07 | $1.35 | +1.73% |
| December 2026 | $0.8723 | $1.06 | $1.36 | -0.69% |
Click any year to see its month-by-month AIFF forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, AIFF is projected to trade between $0.64 and $1.36, averaging $1.17 — a potential gain of 0% from today's $1.17. A consolidation phase looks the most probable path here.
Firefly Neuroscience, Inc.'s 2027 outlook centres on $1.07, within a $0.8283 to $1.47 range. That is -9% versus the projected 2026 average. That marks a -9% change versus current levels. Price action looks broadly range-bound.
By 2028, AIFF could reach as high as $1.54, with a base case around $1.07 and support toward $0.7991 — roughly -9% from $1.17. A consolidation phase looks the most probable path here.
Expect AIFF to range from $0.912 to $1.88 through 2029. The $1.26 average target implies a +8% move from current prices. That is up +18% on the projected 2028 average. Price action looks broadly range-bound.
The AIFF price prediction for 2030 points to an average of $1.37 (low $0.9626, high $2.11) — a potential gain of +17% on today's $1.17. A consolidation phase looks the most probable path here.
In 2031, AIFF is projected to trade between $0.9547 and $2.20, averaging $1.39 — a potential gain of +19% from today's $1.17. That is up +2% on the projected 2030 average. Price action looks broadly range-bound.
Firefly Neuroscience, Inc.'s 2032 outlook centres on $1.45, within a $0.971 to $2.35 range. That is up +4% on the projected 2031 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, AIFF could reach as high as $2.09, with a base case around $1.26 and support toward $0.8261 — roughly +8% from $1.17. Price action looks broadly range-bound.
Expect AIFF to range from $0.8036 to $2.12 through 2034. The $1.26 average target implies a +7% move from current prices. That is -1% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The AIFF price prediction for 2035 points to an average of $1.47 (low $0.9234, high $2.53) — a potential gain of +26% on today's $1.17. Momentum favours further upside here.
In 2040, AIFF is projected to trade between $1.08 and $3.53, averaging $1.91 — a potential gain of +63% from today's $1.17. That is up +29% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Firefly Neuroscience, Inc.'s 2050 outlook centres on $3.36, within a $1.60 to $6.91 range. That is up +76% on the projected 2040 average. That marks a +187% change versus current levels. Momentum favours further upside here.
Investing $1,000 in AIFF today (≈ 854.700855 AIFF) could be worth
$2,869.78
+$1,869.78 (+187%) by 2050 · US Dollar
Based on the average projected AIFF price of $3.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AIFFwould be worth at today's price.
$1,000 invested in AIFF on Jul 31, 2025 (≈ 359.712234 AIFF) would be worth
$420.86
-$579.14 (-57.9%) today · 0.42× · US Dollar
Based on a AIFF entry price of $2.78 vs. today's $1.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.11 | $1,054.05 | +5.4% |
| 1 month ago | $1.29 | $906.98 | -9.3% |
| 3 months ago | $2.27 | $515.42 | -48.5% |
| 6 months ago | $0.86 | $1,360.47 | +36.0% |
| 1 year ago | $2.78 | $420.86 | -57.9% |
| All time (5.0y) ago | $73.8 | $15.85 | -98.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AIFF forecast.
Our base-case forecast reaches $2.30 around 2050.
Implied market cap at $2.30: $35.89M
The multi-year forecast shows a transition from neutral to bullish in later years. In 2030 the average price is $1.18 with a ROI of 17.1 and a neutral sentiment, while 2032 marks the first bullish signal with an average of $1.24 and a ROI of 23.2. The trajectory continues into 2035 with an average of $1.28, a max of $2.16, and a ROI of 26.3, and into 2040 with an average of $1.66, a max of $3.01, and a ROI of 64.
By 2050 the forecast shows an average of $2.90, a max of $5.85, and a ROI of 186.8 with a bullish sentiment. The path includes earlier years with mixed results, including negative ROI in 2027 (-8.2%) and 2028 (-7.4%), underscoring uncertainty. Overall, the long-term outlook points to meaningful upside but remains uncertain and not guaranteed.
Tap a question to reveal the answer.
2030 — min $0.84, avg $1.18, max $1.80; ROI 17.1; sentiment NEUTRAL.
The forecast shows mixed near-term results with some years negative (e.g., 2027 -8.2%; 2028 -7.4%), but longer-term upside with 2040 ROI 64 and 2050 ROI 186.8. These are estimates, not guarantees.
Yes. The 2050 max forecast is $5.85 with ROI 186.8 and sentiment BULLISH.
Current price $1.01; Market cap $15.76M; Rank 4673.
2032 shows sentiment BULLISH; min $0.8427, avg $1.24, max $1.99; ROI 23.2.
Firefly Neuroscience, Inc. Community Discussion
0Share your Firefly Neuroscience, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.